Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Sell
36
ATEC Quote, Financials, Valuation and Earnings
Last price:
$9.94
Seasonality move
:
6.61%
Day range:
$9.81 - $10.19
52-week range:
$4.88 - $14.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.32x
P/B ratio:
56.64x
Volume:
1.8M
Avg. volume:
2.3M
1-year change:
-27.68%
Market cap:
$1.4B
Revenue:
$611.6M
EPS (TTM):
-$1.14
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $144.9M | $243.2M | $350.9M | $482.3M | $611.6M | |
| Revenue Growth (YoY) | 27.71% | 67.89% | 44.26% | 37.45% | 26.81% | |
| Cost of Revenues | $42.4M | $85.5M | $117.8M | $172.1M | $187.3M | |
| Gross Profit | $102.5M | $157.8M | $233.1M | $310.2M | $424.3M | |
| Gross Profit Margin | 70.76% | 64.87% | 66.42% | 64.32% | 69.37% | |
| R&D Expenses | $18.7M | $32M | $44M | $70.1M | $80.7M | |
| Selling, General & Admin | $129.2M | $229.3M | $300M | $374.1M | $450.2M | |
| Other Inc / (Exp) | -$20.4M | -$28.2M | -$25.4M | -$22M | -$14.3M | |
| Operating Expenses | $148.6M | $266.6M | $354.2M | $458.5M | $547.2M | |
| Operating Income | -$46.1M | -$108.9M | -$121.1M | -$148.3M | -$122.9M | |
| Net Interest Expenses | $12.4M | $7.1M | $5.5M | $16.6M | $24.9M | |
| EBT. Incl. Unusual Items | -$78.8M | -$144.2M | -$152M | -$186.9M | -$162.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $145K | -$1.1M | -$716K | -$277K | $50K | |
| Net Income to Company | -$79M | -$143M | -$151.3M | -$186.6M | -$162.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$79M | -$143M | -$151.3M | -$186.6M | -$162.1M | |
| Basic EPS (Cont. Ops) | -$1.18 | -$1.49 | -$1.46 | -$1.54 | -$1.13 | |
| Diluted EPS (Cont. Ops) | -$1.18 | -$1.49 | -$1.46 | -$1.54 | -$1.13 | |
| Weighted Average Basic Share | $67M | $96.2M | $103.4M | $121.2M | $142.9M | |
| Weighted Average Diluted Share | $67M | $96.2M | $103.4M | $121.2M | $142.9M | |
| EBITDA | -$54.8M | -$106.9M | -$102.6M | -$110.6M | -$53.9M | |
| EBIT | -$66.5M | -$137.1M | -$146.5M | -$170.3M | -$137.2M | |
| Revenue (Reported) | $144.9M | $243.2M | $350.9M | $482.3M | $611.6M | |
| Operating Income (Reported) | -$46.1M | -$108.9M | -$121.1M | -$148.3M | -$122.9M | |
| Operating Income (Adjusted) | -$66.5M | -$137.1M | -$146.5M | -$170.3M | -$137.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $44M | $74M | $105.9M | $138M | $176.8M | |
| Revenue Growth (YoY) | 35.86% | 68.27% | 43.24% | 30.23% | 28.14% | |
| Cost of Revenues | $12.6M | $28.7M | $37.1M | $42.8M | $55.2M | |
| Gross Profit | $31.4M | $45.2M | $68.9M | $95.2M | $121.6M | |
| Gross Profit Margin | 71.42% | 61.15% | 64.99% | 68.99% | 68.77% | |
| R&D Expenses | $5.4M | $9M | $11.6M | $22.3M | $23.2M | |
| Selling, General & Admin | $39.7M | $66.7M | $81.9M | $104.1M | $114.5M | |
| Other Inc / (Exp) | -$9.2M | -$6.3M | -$6.4M | -$9.7M | -$4.8M | |
| Operating Expenses | $45.3M | $77.6M | $96.5M | $130.2M | $142.5M | |
| Operating Income | -$13.9M | -$32.4M | -$27.6M | -$35M | -$20.9M | |
| Net Interest Expenses | $3.7M | $1.5M | $1.3M | $4.4M | $7.2M | |
| EBT. Incl. Unusual Items | -$26.8M | -$40.2M | -$35.3M | -$49.2M | -$32.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5K | -$1.3M | -$524K | -$124K | $441K | |
| Net Income to Company | -$26.8M | -$38.9M | -$34.8M | -$49.1M | -$33.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$26.8M | -$38.9M | -$34.8M | -$49.1M | -$33.3M | |
| Basic EPS (Cont. Ops) | -$0.35 | -$0.40 | -$0.33 | -$0.37 | -$0.23 | |
| Diluted EPS (Cont. Ops) | -$0.35 | -$0.40 | -$0.33 | -$0.37 | -$0.23 | |
| Weighted Average Basic Share | $77.1M | $99.2M | $105.8M | $133.9M | $144.6M | |
| Weighted Average Diluted Share | $77.1M | $99.2M | $105.8M | $133.9M | $144.6M | |
| EBITDA | -$20.1M | -$29.2M | -$21.8M | -$27.8M | -$4.3M | |
| EBIT | -$23.1M | -$38.7M | -$34M | -$44.8M | -$25.7M | |
| Revenue (Reported) | $44M | $74M | $105.9M | $138M | $176.8M | |
| Operating Income (Reported) | -$13.9M | -$32.4M | -$27.6M | -$35M | -$20.9M | |
| Operating Income (Adjusted) | -$23.1M | -$38.7M | -$34M | -$44.8M | -$25.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $144.9M | $243.2M | $350.9M | $482.3M | $611.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $42.4M | $85.5M | $117.8M | $172.1M | $187.3M | |
| Gross Profit | $102.5M | $157.8M | $233.1M | $310.2M | $424.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $18.7M | $32M | $44M | $70.1M | $80.7M | |
| Selling, General & Admin | $129.2M | $229.3M | $300M | $374.1M | $450.2M | |
| Other Inc / (Exp) | -$20.4M | -$28.2M | -$25.4M | -$22M | -$14.3M | |
| Operating Expenses | $148.6M | $266.6M | $354.2M | $458.5M | $547.2M | |
| Operating Income | -$46.1M | -$108.9M | -$121.1M | -$148.3M | -$122.9M | |
| Net Interest Expenses | $12.4M | $7.1M | $5.5M | $16.6M | $24.9M | |
| EBT. Incl. Unusual Items | -$78.8M | -$144.2M | -$152M | -$186.9M | -$162.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $145K | -$1.1M | -$716K | -$277K | $50K | |
| Net Income to Company | -$79M | -$143M | -$151.3M | -$186.6M | -$162.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$79M | -$143M | -$151.3M | -$186.6M | -$162.1M | |
| Basic EPS (Cont. Ops) | -$1.17 | -$1.48 | -$1.47 | -$1.55 | -$1.14 | |
| Diluted EPS (Cont. Ops) | -$1.17 | -$1.48 | -$1.47 | -$1.55 | -$1.14 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$54.8M | -$106.9M | -$102.6M | -$110.6M | -$53.9M | |
| EBIT | -$66.5M | -$137.1M | -$146.5M | -$170.3M | -$137.2M | |
| Revenue (Reported) | $144.9M | $243.2M | $350.9M | $482.3M | $611.6M | |
| Operating Income (Reported) | -$46.1M | -$108.9M | -$121.1M | -$148.3M | -$122.9M | |
| Operating Income (Adjusted) | -$66.5M | -$137.1M | -$146.5M | -$170.3M | -$137.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $243.2M | $350.9M | $482.3M | $611.6M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $85.5M | $117.8M | $172.1M | $187.3M | -- | |
| Gross Profit | $157.8M | $233.1M | $310.2M | $424.3M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $32M | $44M | $70.1M | $80.7M | -- | |
| Selling, General & Admin | $229.3M | $300M | $374.1M | $450.2M | -- | |
| Other Inc / (Exp) | -$28.2M | -$25.4M | -$22M | -$14.3M | -- | |
| Operating Expenses | $266.6M | $354.2M | $458.5M | $547.2M | -- | |
| Operating Income | -$108.9M | -$121.1M | -$148.3M | -$122.9M | -- | |
| Net Interest Expenses | $7.1M | $5.5M | $16.6M | $24.9M | -- | |
| EBT. Incl. Unusual Items | -$144.2M | -$152M | -$186.9M | -$162.1M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.1M | -$716K | -$277K | $50K | -- | |
| Net Income to Company | -$143M | -$151.3M | -$186.6M | -$162.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$143M | -$151.3M | -$186.6M | -$162.1M | -- | |
| Basic EPS (Cont. Ops) | -$1.48 | -$1.47 | -$1.55 | -$1.14 | -- | |
| Diluted EPS (Cont. Ops) | -$1.48 | -$1.47 | -$1.55 | -$1.14 | -- | |
| Weighted Average Basic Share | $384.5M | $413.4M | $484.8M | $571.7M | -- | |
| Weighted Average Diluted Share | $384.5M | $413.4M | $484.8M | $571.7M | -- | |
| EBITDA | -$106.9M | -$102.6M | -$110.6M | -$53.9M | -- | |
| EBIT | -$137.1M | -$146.5M | -$170.3M | -$137.2M | -- | |
| Revenue (Reported) | $243.2M | $350.9M | $482.3M | $611.6M | -- | |
| Operating Income (Reported) | -$108.9M | -$121.1M | -$148.3M | -$122.9M | -- | |
| Operating Income (Adjusted) | -$137.1M | -$146.5M | -$170.3M | -$137.2M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $107.8M | $187.2M | $84.7M | $221M | $138.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $23.5M | $41.9M | $60.1M | $72.6M | $83M | |
| Inventory | $46M | $91.7M | $101.5M | $136.8M | $175.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.4M | $10.3M | $9.4M | $20.7M | $20.3M | |
| Total Current Assets | $184.2M | $331.2M | $255.6M | $451.1M | $417.4M | |
| Property Plant And Equipment | $37.8M | $112.7M | $130.3M | $176.2M | $191.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $13.9M | $39.7M | $47.4M | $73M | $71M | |
| Other Intangibles | $24.7M | $85.3M | $82.8M | $102.5M | $93.5M | |
| Other Long-Term Assets | $599K | $3.2M | $4.9M | $2.4M | $2.7M | |
| Total Assets | $261.2M | $572.1M | $521M | $805.2M | $775.7M | |
| Accounts Payable | $17.6M | $25.7M | $34.7M | $49M | $53M | |
| Accrued Expenses | $33.3M | $48.3M | $64.8M | $77.7M | $74.6M | |
| Current Portion Of Long-Term Debt | $4.2M | $342K | $14.9M | $1.8M | $1.7M | |
| Current Portion Of Capital Lease Obligations | $885K | $4.2M | $4.8M | $5.2M | $6.5M | |
| Other Current Liabilities | $2.1M | $4.3M | $5.6M | $8M | $4.3M | |
| Total Current Liabilities | $58.3M | $101.1M | $138.9M | $157.6M | $153M | |
| Long-Term Debt | $38M | $326.5M | $349.5M | $511M | $574.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $131.3M | $492.6M | $555.6M | $727.1M | $789.9M | |
| Common Stock | $8K | $10K | $11K | $14K | $14K | |
| Other Common Equity Adj | $1.2M | -$6M | -$10.8M | -$8.3M | -$13.7M | |
| Common Equity | $129.9M | $79.4M | -$34.7M | $78.1M | -$14.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $129.9M | $79.4M | -$34.7M | $78.1M | -$14.2M | |
| Total Liabilities and Equity | $261.2M | $572.1M | $521M | $805.2M | $775.7M | |
| Cash and Short Terms | $107.8M | $187.2M | $84.7M | $221M | $138.8M | |
| Total Debt | $42.2M | $326.8M | $364.5M | $512.8M | $576.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $107.8M | $187.2M | $84.7M | $221M | $138.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $23.5M | $41.9M | $60.1M | $72.6M | $83M | |
| Inventory | $46M | $91.7M | $101.5M | $136.8M | $175.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.4M | $10.3M | $9.4M | $20.7M | $20.3M | |
| Total Current Assets | $184.2M | $331.2M | $255.6M | $451.1M | $417.4M | |
| Property Plant And Equipment | $37.8M | $112.7M | $130.3M | $176.2M | $191.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $13.9M | $39.7M | $47.4M | $73M | $71M | |
| Other Intangibles | $24.7M | $85.3M | $82.8M | $102.5M | $93.5M | |
| Other Long-Term Assets | $599K | $3.2M | $4.9M | $2.4M | $2.7M | |
| Total Assets | $261.2M | $572.1M | $521M | $805.2M | $775.7M | |
| Accounts Payable | $17.6M | $25.7M | $34.7M | $49M | $53M | |
| Accrued Expenses | $33.3M | $48.3M | $64.8M | $77.7M | $74.6M | |
| Current Portion Of Long-Term Debt | $4.2M | $342K | $14.9M | $1.8M | $1.7M | |
| Current Portion Of Capital Lease Obligations | $885K | $4.2M | $4.8M | $5.2M | $6.5M | |
| Other Current Liabilities | $2.1M | $4.3M | $5.6M | $8M | $4.3M | |
| Total Current Liabilities | $58.3M | $101.1M | $138.9M | $157.6M | $153M | |
| Long-Term Debt | $38M | $326.5M | $349.5M | $511M | $574.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $131.3M | $492.6M | $555.6M | $727.1M | $789.9M | |
| Common Stock | $8K | $10K | $11K | $14K | $14K | |
| Other Common Equity Adj | $1.2M | -$6M | -$10.8M | -$8.3M | -$13.7M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $129.9M | $79.4M | -$34.7M | $78.1M | -$14.2M | |
| Total Liabilities and Equity | $261.2M | $572.1M | $521M | $805.2M | $775.7M | |
| Cash and Short Terms | $107.8M | $187.2M | $84.7M | $221M | $138.8M | |
| Total Debt | $42.2M | $326.8M | $364.5M | $512.8M | $576.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$79M | -$143M | -$151.3M | -$186.6M | -$162.1M | |
| Depreciation & Amoritzation | $11.6M | $30.2M | $43.9M | $59.7M | $83.3M | |
| Stock-Based Compensation | $17.7M | $36.5M | $40.6M | $81.2M | $73.3M | |
| Change in Accounts Receivable | -$7.5M | -$10.1M | -$18.8M | -$12.8M | -$14.6M | |
| Change in Inventories | -$18.2M | -$27.7M | -$20.7M | -$45.6M | -$54.7M | |
| Cash From Operations | -$46.4M | -$73.3M | -$75.1M | -$78.5M | -$44.7M | |
| Capital Expenditures | $23.9M | $68.5M | $58.3M | $87M | $93.1M | |
| Cash Acquisitions | -- | -$83.2M | -- | -$55M | -- | |
| Cash From Investing | -$23.9M | -$157.8M | -$58.3M | -$142M | -$93.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $76.5M | $316.3M | $62.5M | $282.5M | $223M | |
| Long-Term Debt Repaid | -$56.6M | -$45M | -$27.5M | -$132.8M | -$164.2M | |
| Repurchase of Common Stock | -- | -$31M | -$3M | -$1.1M | -- | |
| Other Financing Activities | -$58K | -$60.1M | -$731K | -$4.9M | -$2M | |
| Cash From Financing | $130.8M | $312M | $31.2M | $356.9M | $56.2M | |
| Beginning Cash (CF) | $47.1M | $107.8M | $187.2M | $84.7M | $221M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $60.6M | $80.9M | -$102.2M | $136.5M | -$81.6M | |
| Ending Cash (CF) | $107.8M | $187.2M | $84.7M | $221M | $138.8M | |
| Levered Free Cash Flow | -$70.3M | -$141.9M | -$133.4M | -$165.5M | -$137.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$26.8M | -$38.9M | -$34.8M | -$49.1M | -$33.3M | |
| Depreciation & Amoritzation | $3M | $9.5M | $12.2M | $17M | $21.4M | |
| Stock-Based Compensation | $5M | $9.7M | $10.1M | $20.5M | $21.5M | |
| Change in Accounts Receivable | $715K | -$8.7M | -$8.7M | -$7.9M | -$5.1M | |
| Change in Inventories | -$5.5M | -$3.9M | -$573K | -$9.5M | $2.4M | |
| Cash From Operations | -$6.7M | -$14.7M | -$8.4M | -$25M | $10.5M | |
| Capital Expenditures | $11M | $19.6M | $14.8M | $28.2M | $3.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$11M | -$20M | -$14.8M | -$28.2M | -$3.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$4K | -- | $27.5M | $42M | $100.8M | |
| Long-Term Debt Repaid | -- | $1.6M | -$27.5M | -$37M | -$53.8M | |
| Repurchase of Common Stock | -- | -$6M | -- | -- | -- | |
| Other Financing Activities | -$10K | -$2M | -$125K | -$452K | -$555K | |
| Cash From Financing | $109.8M | -$487K | $1M | $151.6M | $50.6M | |
| Beginning Cash (CF) | $15.7M | $223.9M | $106.1M | $122.5M | $81M | |
| Foreign Exchange Rate Adjustment | $12K | -$1.4M | $809K | $90K | $445K | |
| Additions / Reductions | $92.1M | -$35.2M | -$22.2M | $98.4M | $57.4M | |
| Ending Cash (CF) | $107.8M | $187.2M | $84.7M | $221M | $138.8M | |
| Levered Free Cash Flow | -$17.7M | -$34.3M | -$23.2M | -$53.2M | $6.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$79M | -$143M | -$151.3M | -$186.6M | -$162.1M | |
| Depreciation & Amoritzation | $11.6M | $30.2M | $43.9M | $59.7M | $83.3M | |
| Stock-Based Compensation | $17.7M | $36.5M | $40.6M | $81.2M | $73.3M | |
| Change in Accounts Receivable | -$7.5M | -$10.1M | -$18.8M | -$12.8M | -$14.6M | |
| Change in Inventories | -$18.2M | -$27.7M | -$20.7M | -$45.6M | -$54.7M | |
| Cash From Operations | -$46.4M | -$73.3M | -$75.1M | -$78.5M | -$44.7M | |
| Capital Expenditures | $23.9M | $68.5M | $58.3M | $87M | $93.1M | |
| Cash Acquisitions | -- | -$83.2M | -- | -$55M | -- | |
| Cash From Investing | -$23.9M | -$157.8M | -$58.3M | -$142M | -$93.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $76.5M | -- | $62.5M | $282.5M | $223M | |
| Long-Term Debt Repaid | -$56.6M | -- | -$27.5M | -$132.8M | -$164.2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$60.1M | -$731K | -$4.9M | -$2M | |
| Cash From Financing | $130.8M | $312M | $31.2M | $356.9M | $56.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $60.6M | $80.9M | -$102.2M | $136.5M | -$81.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$70.3M | -$141.9M | -$133.4M | -$165.5M | -$137.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$143M | -$151.3M | -$186.6M | -$162.1M | -- | |
| Depreciation & Amoritzation | $30.2M | $43.9M | $59.7M | $83.3M | -- | |
| Stock-Based Compensation | $36.5M | $40.6M | $81.2M | $73.3M | -- | |
| Change in Accounts Receivable | -$10.1M | -$18.8M | -$12.8M | -$14.6M | -- | |
| Change in Inventories | -$27.7M | -$20.7M | -$45.6M | -$54.7M | -- | |
| Cash From Operations | -$73.3M | -$75.1M | -$78.5M | -$44.7M | -- | |
| Capital Expenditures | $68.5M | $58.3M | $87M | $93.1M | -- | |
| Cash Acquisitions | -$83.2M | -- | -$55M | -- | -- | |
| Cash From Investing | -$157.8M | -$58.3M | -$142M | -$93.1M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $316.3M | $62.5M | $282.5M | $223M | -- | |
| Long-Term Debt Repaid | -$45M | -$27.5M | -$132.8M | -$164.2M | -- | |
| Repurchase of Common Stock | -$31M | -- | -- | -- | -- | |
| Other Financing Activities | -$60.1M | -$731K | -$4.9M | -$2M | -- | |
| Cash From Financing | $312M | $31.2M | $356.9M | $56.2M | -- | |
| Beginning Cash (CF) | $599.4M | $552.6M | $424.9M | $545.9M | -- | |
| Foreign Exchange Rate Adjustment | -$1.4M | -$366K | -$185K | -$551K | -- | |
| Additions / Reductions | $80.9M | -$102.2M | $136.5M | -$81.6M | -- | |
| Ending Cash (CF) | $678.8M | $450.1M | $561.2M | $463.7M | -- | |
| Levered Free Cash Flow | -$141.9M | -$133.4M | -$165.5M | -$137.8M | -- | |
Get ATEC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ATEC
Sector
P/E ratio
--
24.27x
PEG ratio
-2.51x
0.00x
P/B ratio
56.64x
1.71x
Price / LTM sales
2.32x
1.71x
Growth Metrics
ATEC
Sector
Revenue growth
28.14%
6.42%
Earnings growth
--
6.3%
Revenue (5-year growth)
40.07%
8.99%
Earnings forecast
-$0.06
-$0.20
Profitability
ATEC
Sector
Profitability FY 2024
$424.3M
$56.6M
Return on invested capital
-29.29%
-14.62%
Return on assets
-20.95%
-11.82%
Return on equity
-691.37%
-16.83%
Earnings Date
Last Earnings Date
Feb
26
Next Earnings Date
May
7
Estimated Next Earnings Date
May
28
Balance Sheet
ATEC
Sector
Total cash
$138.8M
$42.2M
Short term investments
--
$37.8M
Total assets
$775.7M
$127.4M
Long term debt
$576.2M
$9.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
